SpinChip Diagnostics ASA secures NOK 60 million in private placement

Oslo, Norway, 19 November 2024 – SpinChip Diagnostics ASA (“SpinChip”) is pleased to announce the completion of its financing round, successfully securing NOK 60 million in the form of a private placement. The financing round was solely directed towards the Company’s shareholders and was significantly oversubscribed. Coherently, the company would like to extend its gratitude to all shareholders participating in the financing round.

The proceeds from the financing round will be used to further advance SpinChip’s proprietary point-of-care (POC) in vitro diagnostics platform, prepare for a CE mark filing in 2025, and for general corporate purposes.

ABG Sundal Collier and Carnegie Investment Bank acted as joint book-runners (the “Joint Bookrunners”) for the financing round, while Wiersholm acted as legal advisors to the company.